Will Rocket Lab’s massive $8 billion bet to challenge SpaceX’s Starlink pay off, or has the company bitten off more than it can chew?
How does the Rocket Lab Iridium Acquisition transform the company?
By securing the Rocket Lab Iridium Acquisition, Rocket Lab USA, Inc. is transitioning from a specialized launch provider into a fully vertically integrated space powerhouse. The $8 billion cash-and-stock transaction, valued at $54 per share, allows the company to bypass years of infrastructure development by immediately acquiring Iridium’s active orbital network of 66 low-Earth-orbit (LEO) satellites.
This network utilizes L-band spectrum technology, which ensures global connectivity even during severe weather conditions. Crucially, this acquisition gives the company a direct path to compete with SpaceX and its highly profitable Starlink division. Iridium brings a robust financial foundation to the table, boasting 2.5 million paid subscribers and $871.7 million in revenue in 2025, alongside a highly attractive 57% operational EBITDA margin.
What are the key technical levels for Rocket Lab stock?
Despite the long-term potential of the Rocket Lab Iridium Acquisition, short-term market dynamics have put pressure on the stock. During Monday’s intraday trading, shares fell 6.16% to $76.08, testing critical support levels. The stock is currently trading 16.5% below its 20-day Simple Moving Average (SMA) and 26.8% below its 50-day SMA, indicating short-term bearish pressure.
However, long-term support remains intact as the stock trades just around its 200-day SMA of $76.92. This area has become a key battleground for buyers and sellers. The MACD momentum indicator remains below its signal line with a negative histogram, suggesting that near-term upside pressure is fading. Traders are watching this $76.92 support zone closely; a breakdown below this level could trigger a broader risk-off selloff, while holding it could spark a sharp rebound.
How do Wall Street analysts view the transaction?
Despite the recent stock price pullback, Wall Street analysts maintain a highly optimistic outlook on the company’s growth trajectory. The consensus rating remains a Buy, with an average price target of $104.73. Individual investment banks have recently updated their assessments to reflect the company’s expanding market footprint.
BofA Securities maintains a Buy rating and recently raised its price target to $115.00. Cantor Fitzgerald reiterates an Overweight rating with a price target of $96.00, while Citizens rates the stock as Market Outperform with an elevated price target of $130.00. Investors are also looking forward to the upcoming quarterly earnings report on August 6, 2026. Analysts estimate a narrowed EPS loss of 7 cents (compared to a loss of 13 cents YoY) and a significant revenue jump to $231.79 million, up from $144.50 million in the prior-year period.
Related Coverage
For a deeper dive into the financial mechanics of this transaction, read our analysis on the Rocket Lab Acquisition: Is the $8B Iridium Deal RKLB’s Boom?, which explores whether this massive investment will successfully transform the company into a defense and space powerhouse. Additionally, the broader aerospace market is experiencing notable volatility; you can read about recent industry shifts in SpaceX IPO Drops -4.7%: Is the Wall Street Hype Fading? to understand how competitors are performing on Wall Street.
